General Information of the Compound
Compound ID
CP0116921
Compound Name
1N-{4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolinyl)ethyl]phenyl}-4,5-dimethoxy-2-(3-quinolylcarboxamido)benzamide
    Show/Hide
Synonyms
N-(2-((4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide
N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide
Tariquidar
Tariquidar (USAN/INN)
Tariquidarth
XR 9576
XR9576
    Show/Hide
Structure
Formula
C38H38N4O6
Molecular Weight
646.744
Canonical SMILES
COc1cc2CCN(CCc3ccc(NC(=O)c4cc(OC)c(OC)cc4NC(=O)c4cnc5ccccc5c4)cc3)Cc2cc1OC
    Show/Hide
InChI
InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43)
    Show/Hide
InChIKey
LGGHDPFKSSRQNS-UHFFFAOYSA-N
CAS
206873-63-4
Physicochemical Property
logP
6.3746
Rotatable Bonds
11
Heavy Atom Count
48
Polar Areas
111.25
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
8
Complexity
48

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 148201
SID: 14765736
ChEMBL ID
CHEMBL348475
DrugBank ID
DB06240
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000355 MES-SA/Dx5 Homo sapiens (Human)  1
1
EC50 = 16 nM
   TI
   LI
   LO
   TS
CL000031 MDCK Canis lupus familiaris (Dog)  2
1
EC50 = 44 nM
   TI
   LI
   LO
   TS
2
IC50 = 210 nM
   TI
   LI
   LO
   TS
CL000357 CEM/VLB500 Homo sapiens (Human)  1
1
EC50 = 68 nM
   TI
   LI
   LO
   TS
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  2
1
EC50 = 211 nM
   TI
   LI
   LO
   TS
2
IC50 >= 1180 nM
   TI
   LI
   LO
   TS
CL000072 A2780 Homo sapiens (Human)  2
1
IC50 = 72.44 nM
   TI
   LI
   LO
   TS
2
IC50 = 125.89 nM
   TI
   LI
   LO
   TS
CL000135 A2780ADR Homo sapiens (Human)  1
1
IC50 = 78 nM
   TI
   LI
   LO
   TS
CL000356 KB-V1 Homo sapiens (Human)  2
1
IC50 = 223 nM
   TI
   LI
   LO
   TS
2
IC50 = 356 nM
   TI
   LI
   LO
   TS
CL000137 K562/A02 Homo sapiens (Human)  7
1
IC50 = 460 nM
   TI
   LI
   LO
   TS
2
IC50 = 1600 nM
   TI
   LI
   LO
   TS
3
IC50 = 1970 nM
   TI
   LI
   LO
   TS
4
IC50 = 3020 nM
   TI
   LI
   LO
   TS
5
IC50 = 4970 nM
   TI
   LI
   LO
   TS
6
IC50 = 8280 nM
   TI
   LI
   LO
   TS
7
IC50 = 14390 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 32.7 nM
Protein ID: PT02718, Broad substrate specificity ATP-binding cassette transporter ABCG2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000031 MDCK Canis lupus familiaris (Dog)  3
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
2
IC50 = 850 nM
   TI
   LI
   LO
   TS
3
IC50 = 940 nM
   TI
   LI
   LO
   TS
CL000781 MCF7/Topo Homo sapiens (Human)  3
1
IC50 = 520 nM
   TI
   LI
   LO
   TS
2
IC50 = 526 nM
   TI
   LI
   LO
   TS
3
IC50 = 916 nM
   TI
   LI
   LO
   TS
CL000756 MCF/MX Homo sapiens (Human)  2
1
IC50 = 680 nM
   TI
   LI
   LO
   TS
2
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CL000083 MCF-7 Homo sapiens (Human)  1
1
IC50 = 1445.44 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 100 nM
2 IC50 = 183.3 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000002 K-562 Homo sapiens (Human)  1
1
IC50 = 31560 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Tariquidar )
Drug Name Tariquidar
Company Xenova Group Ltd.
Indication
Adrenocortical carcinoma
Discontinued in Phase 2
Target(s)
Multidrug resistance protein 1 (ABCB1)
Modulator